Welcome to our dedicated page for Uipath news (Ticker: PATH), a resource for investors and traders seeking the latest updates and insights on Uipath stock.
Stay informed about UiPath Inc. (PATH), the leader in enterprise robotic process automation, through our comprehensive news repository. This page aggregates official press releases, financial disclosures, and market analysis related to UiPath's automation solutions that combine AI, machine learning, and API integrations.
Investors and industry professionals will find timely updates on quarterly earnings, product innovations, and strategic partnerships. Our curated collection includes details on UiPath's expanding automation ecosystem, integration capabilities with major business platforms, and evolving applications across finance, healthcare, and technology sectors.
All content undergoes strict verification to ensure accuracy and relevance. Bookmark this page for real-time updates on UiPath's market position, regulatory filings, and leadership developments within the competitive RPA landscape. Check regularly for insights into how the company's automation technologies continue reshaping global business processes.
UiPath (NYSE: PATH) announced the launch of its generative AI-based Medical Record Summarization agent, powered by Google Cloud Vertex AI and Gemini models, at Google Cloud Next 2025. The solution, currently in private preview, aims to reduce prior authorization turn-around time by up to 50%.
The AI agent, developed with clinical professionals, can complete medical record summarization in minutes compared to the typical 45-minute manual process. Key benefits include saving up to 40 minutes per referral, ensuring consistent quality with standardized sections, and providing traceable data for improved clinical decisions.
The solution is already showing results with a major healthcare payer achieving 23% faster document processing. The partnership leverages Google Cloud's Vertex AI and Gemini 2.0 Flash, offering clinician-level summaries and state-of-the-art retrieval-augmented generation (RAG) for processing unstructured medical data.
UiPath (NYSE: PATH) has launched Test Cloud, an AI-powered software testing solution aimed at revolutionizing quality assurance processes. The platform introduces agentic testing through two key components: Autopilot for Testers and Agent Builder, designed to reduce the typical 25% IT budget spent on traditional testing methods.
According to an IDC study, organizations using Test Cloud have achieved:
- 36% improvement in test efficiency
- 2x increase in new feature delivery throughput
- 50% reduction in outages
- 93% decrease in troubleshooting time
The solution offers resilient end-to-end automation for modern and enterprise applications, with enterprise-ready AI capabilities integrated within CI/CD pipelines. Cisco has reported cutting its manual testing efforts by nearly half using Autopilot, allowing testing teams to focus on more strategic tasks.
UiPath (NYSE: PATH) has launched a free 60-day trial of its Automation Cloud Public Sector solution, specifically designed for U.S. government agencies. The cloud-based platform, which holds FedRAMP Moderate compliance, aims to help public sector organizations improve operational efficiency and handle sensitive data securely.
The solution offers critical automation capabilities including process mining, AI-powered Document Understanding, unattended and attended robots, and low-code apps. Key benefits include decreased administrative costs, improved spend management, and accelerated document processing with machine learning models.
The company is also hosting the UiPath on Tour Agentic Automation Summit in Washington, D.C. on April 29, themed 'Ushering in the Era of Efficiency', where government leaders will discuss agency transformation initiatives.
UiPath (NYSE: PATH) announced its annual Agentic AI Summit, scheduled for March 25, showcasing the company's latest agentic automation innovations. The virtual event will demonstrate how UiPath's platform integrates AI agents, robots, and people to streamline operations and automate complex business processes.
The summit will feature customer success stories from WEX, State Street, and Adobe, highlighting practical applications of agentic automation. Key announcements include the public preview of UiPath Agentic Orchestration, which coordinates processes between agents, robots, and humans, and Agent Builder for creating ecosystem-agnostic AI agents.
UiPath will also launch Test Cloud, a new AI-powered software testing solution designed to enhance tester productivity and reduce costs. The event will be broadcast in three time zones (GMT, EDT, and AEDT) and will cover industry-specific implementations in banking, healthcare, manufacturing, and departmental applications in finance, legal, and HR.
UiPath (NYSE: PATH) has acquired Peak, an AI-native company from Manchester, UK, to enhance its vertical AI solutions strategy. Peak's AI platform specializes in optimizing product inventory and pricing for businesses across various industries. The acquisition will integrate Peak's purpose-built AI applications into UiPath's agentic automation platform.
Peak's technology enables AI workflow development, data processing, and predictive capabilities through APIs and web applications, particularly focusing on complex business decisions like inventory planning and pricing optimization. The merger aims to scale Peak's solutions globally while accelerating AI adoption in retail and manufacturing sectors.
A successful example of their existing partnership includes transforming the quote pricing process for Heidelberg Materials in the UK, where automation and AI combine to determine optimal customer quotes, resulting in improved sales team efficiency and higher conversion rates.
UiPath (NYSE: PATH) reported strong Q4 fiscal 2025 results with revenue reaching $424 million, up 5% year-over-year. The company achieved an Annual Recurring Revenue (ARR) of $1.666 billion, marking a 14% increase year-over-year, with net new ARR of $60 million.
Q4 highlights include a GAAP operating income of $34 million and non-GAAP operating income of $134 million. The company maintained strong financials with a dollar-based net retention rate of 110% and cash reserves of $1.7 billion.
For full-year fiscal 2025, UiPath recorded revenue of $1.430 billion, up 9% year-over-year, with net new ARR of $202 million. The company announced the acquisition of Peak AI to enhance its AI capabilities in retail and manufacturing sectors.
Looking ahead to fiscal 2026, UiPath projects Q1 revenue between $330-335 million and full-year revenue of $1.525-1.530 billion, while noting increased global macroeconomic uncertainty, particularly in the U.S. public sector.
UiPath (NYSE: PATH) has secured a new global consulting agreement with a major Electronic Medical Records (EMR) platform, expanding its professional services to 16 new countries including Australia, France, Germany, Italy, Singapore, and Sweden. The agreement accelerates customer and partner access to EMR platform services from weeks to days.
This expansion aims to address healthcare efficiency challenges, as the EMR market for hospital systems is projected to exceed $20 billion in 2025. UiPath's automation and AI solutions focus on reducing administrative burden, improving revenue integrity, and optimizing interoperability in healthcare operations.
The company is also advancing its agentic automation capabilities, which combine large language models (LLMs), generative AI, and large action models (LAMs) to enable autonomous software agents that can perceive, reason, and execute tasks without constant human direction.
UiPath (NYSE: PATH), a leading enterprise automation and AI software company, has scheduled its fourth quarter and full year fiscal 2025 financial results announcement for Wednesday, March 12, 2025, after market close. The company will host a conference call and webcast at 5:00 PM ET to discuss the results.
Investors and interested parties can access the live call via US/Canada toll-free number (1-877-407-8309) or toll number (1-201-689-8057) using conference ID 13751756. A webcast replay will be available on the company's investor relations website for one year following the call.
UiPath (NYSE: PATH) announced its participation at the ViVE 2025 conference in Nashville from February 17-19, 2025, where it will showcase its Agentic Automation capabilities at booth #738. The company's technology combines robots and agents to handle complex work tasks in healthcare, including medical policy QA, revenue cycle management, and medical record summarization.
A key highlight is the efficiency gain in medical record summarization, where agents can complete tasks in minutes compared to the 30-60 minutes typically required by clinicians. Mayo Clinic executives will join UiPath's Jason Warrelmann to discuss their automation journey, focusing on how they're scaling automation to enhance patient care while reducing administrative burdens.
Warrelmann will also present on how the combination of agentic automation and robotic process automation enables healthcare organizations to maximize AI value, providing insights into AI-driven agents being developed for healthcare.
UiPath (NYSE: PATH) released a report showing strong interest in agentic AI among IT executives. 90% of U.S. IT executives believe their business processes would benefit from agentic AI, and 77% plan to invest in it this year. The study, surveying over 250 IT executives at billion-dollar companies, revealed that 37% are already using agentic AI, with 93% expressing strong interest in exploring it.
Key benefits cited include improved workflow oversight (58%), increased application integration (53%), and complex workflow automation (52%). However, executives identified significant challenges, including IT security (56%), implementation costs (37%), and system integration (35%). 87% of respondents emphasized the importance of interoperability between AI technologies.
FAQ
What is the current stock price of Uipath (PATH)?
What is the market cap of Uipath (PATH)?
